|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00512 GRAND PHARMA
Nominal 
4.750 0.000 (0.000%) | 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Turnover | 6,047,236 | 0.964% | 5,989,486 | 5,212,581 | 4,566,530 | 3,255,784 |
| Cost of Sales | (2,455,927) | 15.788% | (2,121,049) | (1,952,487) | (1,673,689) | (1,215,195) |
| Gross Profit | 3,591,309 | -7.164% | 3,868,437 | 3,260,094 | 2,892,841 | 2,040,589 |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 443,749 | 161.020% | 170,006 | (392,560) | 298,892 | (6,000) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 18,816 | -- | (6,811) | (48,382) | 23,209 | 62,159 | |
| Profit / (Loss) before Taxation | 1,831,882 | 38.183% | 1,325,697 | 915,700 | 1,408,536 | 871,321 | |
| Taxation | (244,175) | -9.204% | (268,926) | (217,777) | (204,299) | (165,505) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (29,762) | 8.553% | (27,417) | 12,488 | (1,694) | 12,693 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,557,945 | 51.352% | 1,029,354 | 710,411 | 1,202,543 | 718,509 | |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Net Finance Costs / (Income) | 86,121 | -23.944% | 113,233 | 63,213 | 23,671 | 58,116 |
| Depreciation & Amortisation | 249,159 | 30.072% | 191,555 | 172,539 | 158,302 | 129,194 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 44.410 | 52.507% | 29.120 | 20.160 | 33.880 | 21.270 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 4.428 | -- | 4.071 | 3.827 | 3.421 | 2.582 |
| Remarks: | Real time quote last updated: 27/12/2024 16:41 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 1,557,945 |
| %Change | 51.352% |
| EPS / (LPS) | HKD 0.444 |
| NBV Per Share ($) | HKD 4.428 |